Overactivation of these pathways contributes to oxidative stress and endothelial dysfunction in hypertension, lipid imbalances in dyslipidemia, mitochondrial damage in chronic kidney disease and insulin signaling impairment in diabetes (Figure 1). The gene discussed is INS; the disease is metabolic syndrome.